These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Exempt 2009-015758-39 Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination with Cisplatin, Fluourouracil and Docetaxel (DCF) in Locally Advanced or Metastatic Cancer of the Stomach and Gastro-oe... 2015-12-12 not-yet-due
Not reported 2010-022520-73 Phase II, open-label non-randomized trial to investigate the efficacy of Bevacizumab in combination with dose dense sequential chemotherapy in the neo-adjuvant setting for HER2 negative breast cancer ... 2015-12-17 due-trials
Not reported 2011-000879-14 A Phase II Trial of Pazopanib, in Relapsed and Refractory Small Cell Lung Cancer (SCLC). 2015-12-10 due-trials
Not reported 2011-002087-24 A phase II study of Temsirolimus in patients with advanced hormone - and chemotherapy - resistant prostate cancer. 2015-10-30 due-trials
Not reported 2012-000275-16 A pilot phase II trial of cabazitaxel in patients with metastatic NSCLC progressing after docetaxel-based treatment 2014-05-06 due-trials
Not reported 2012-002179-32 A Multicenter, Phase II, Single-Arm Clinical Trial of nab-Paclitaxel as salvage treatment for patients with Locally Advanced or Metastatic Adenocarcinomas of the Stomach and Gastro-esophageal junction 2015-12-03 due-trials
Ongoing 2014-001422-16 An open label, non-randomized, phase two trial in metastatic colorectal cancer (mCRC) with the combination of mFOLFIRI plus Aflibercept as first treatment: MINOAS trial not-yet-due
Completed, but no date 2016-001335-12 A longitudinal study evaluating molecular changes associated with resistance to first and third (AZD9291) generation EGFR TKIs in patients with EGFR mutant NSCLC using "liquid biopsy" bad-data